MELBOURNE: Clinuvel Pharmaceuticals is investing in the further expansion of its facilities in Singapore with new state of the art and expanded laboratories to open 1 July 2020. The research and development capacity of its wholly owned subsidiary, Vallaurix Pte Ltd, will be expanded through both a new biological and analytical laboratory, which will work…